SCHEMBL14063869

SCHEMBL14063869

CC(C)NC(=O)CN1CCN(C(=O)c2ccc(Nc3nccc(-c4ccc(SCC(C)(C)CO)cc4)n3)cc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 1/20 0.44
▸ CDK2 P24941 1/20 0.44
▸ IKBKB O14920 7/20 0.43
▸ CHUK O15111 6/20 0.43
▸ IKBKG Q9Y6K9 6/20 0.43
▸ MTOR P42345 1/20 0.43
▸ SMG1 Q96Q15 1/20 0.43
▸ MYLK4 Q86YV6 2/20 0.42
▸ STK17A Q9UEE5 2/20 0.42
▸ NEK3 P51956 1/20 0.42
▸ LIMK1 P53667 1/20 0.42
▸ NEK5 Q6P3R8 1/20 0.42
▸ JAK2 O60674 6/20 0.42
▸ HDAC1 Q13547 2/20 0.42
▸ HDAC6 Q9UBN7 2/20 0.42
▸ JAK3 P52333 3/20 0.41
▸ PLK4 O00444 1/20 0.41
▸ NOS3 P29474 1/20 0.40
▸ NOS1 P29475 1/20 0.40
▸ BTK Q06187 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14063854 0.90 CDK2 (0.46) CDK1CDK2IKBKBCHUKIKBKG
SCHEMBL8308468 0.89 SYK (0.47) CDK1CDK2IKBKBCHUKIKBKG
SCHEMBL14063861 0.89 IKBKB (0.47) CDK1CDK2IKBKBCHUKIKBKG
SCHEMBL14021069 0.89 JAK2 (0.46) CDK1CDK2IKBKBCHUKIKBKG
SCHEMBL8313394 0.88 IKBKB (0.46) CDK1CDK2IKBKBCHUKIKBKG
SCHEMBL14063867 0.87 JAK2 (0.46) CDK1CDK2IKBKBCHUKIKBKG
SCHEMBL14021585 0.86 CDK1 (0.53) CDK1CDK2IKBKBCHUKIKBKG
SCHEMBL14021233 0.85 CDK1 (0.49) CDK1CDK2IKBKBCHUKIKBKG
SCHEMBL8309514 0.85 JAK2 (0.45) CDK1CDK2IKBKBCHUKIKBKG
SCHEMBL8315467 0.84 IKBKB (0.52) IKBKBCHUKIKBKGJAK2PLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
Send feedback